Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a Biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases. The headquarters is in USA.
Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2022 was 214 million USD and and Net Income for year ending Dec-2022 was 83 million USD.
Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2021 was 140 million USD and and Net Income for year ending Dec-2021 was 39 million USD.
As on 2022, Catalyst Pharmaceuticals has 82 employees.